A novel interaction of outer membrane protein A with C4b binding protein mediates serum resistance of Escherichia coli K1

被引:140
作者
Prasadarao, NV
Blom, AM
Villoutreix, BO
Linsangan, LC
机构
[1] Childrens Hosp Los Angeles, Div Infect Dis, Los Angeles, CA 90027 USA
[2] Univ So Calif, Keck Sch Med, Los Angeles, CA 90027 USA
[3] Lund Univ, Malmo Univ Hosp, Dept Clin Chem, Malmo, Sweden
[4] Univ Paris 05, INSERM, U428, Paris, France
关键词
D O I
10.4049/jimmunol.169.11.6352
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Escherichia coli is an important pathogen that causes meningitis in neonates. The development of bacteremia preceding the traversal across the blood-brain barrier is a prerequisite for this pathogen that obviously must survive the bactericidal activity of serum. Here we report that outer membrane protein A (OmpA) of Escherichia coli contributes to serum resistance by binding to C4b binding protein (C4bp), a complement fluid phase regulator. C4bp contains seven identical alpha-chains and one beta-chain linked together with disulfide bridges. We found that OmpA binds the alpha-chain of C4bp, which is composed of eight homologous complement control protein (CCP) modules. Binding studies using mutants of recombinant C4bp that lack one CCP at a time suggest that CCP3 is the major site of interaction with OmpA. Furthermore, we demonstrate that the N terminus of OmpA interacts with C4bp. Binding of C4bp to OmpA is not significantly inhibited in the presence of either C4b or heparin and is not salt sensitive, implying that it is hydrophobic in nature, suggesting a novel interaction between OmpA and C4bp. A compelling observation in this study is that synthetic peptides corresponding to CCP3 sequences block the binding of C4bp to OmpA and also significantly enhance serum bactericidal activity.
引用
收藏
页码:6352 / 6360
页数:9
相关论文
共 33 条
[1]  
Berggard K, 1997, INFECT IMMUN, V65, P3638
[2]   Binding of human C4BP to the hypervariable region of M protein:: a molecular mechanism of phagocytosis resistance in Streptococcus pyogenes [J].
Berggård, K ;
Johnsson, E ;
Morfeldt, E ;
Persson, J ;
Stålhammar-Carlemalm, M ;
Lindahl, G .
MOLECULAR MICROBIOLOGY, 2001, 42 (02) :539-551
[3]  
Berggärd K, 2001, EUR J IMMUNOL, V31, P2771, DOI 10.1002/1521-4141(200109)31:9<2771::AID-IMMU2771>3.0.CO
[4]  
2-0
[5]   Human C4b-binding protein has overlapping, but not identical, binding sites for C4b and streptococcal M proteins [J].
Blom, AM ;
Berggård, K ;
Webb, JH ;
Lindahl, G ;
Villoutreix, BO ;
Dahlbäck, B .
JOURNAL OF IMMUNOLOGY, 2000, 164 (10) :5328-5336
[6]   A cluster of positively charged amino acids in the C4BP α-chain is crucial for C4b binding and factor I cofactor function [J].
Blom, AM ;
Webb, J ;
Villoutreix, BO ;
Dahlbäck, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (27) :19237-19245
[7]   A novel interaction between type IV pili of Neisseria gonorrhoeae and the human complement regulator C4b-binding protein [J].
Blom, AM ;
Rytkönen, A ;
Vasquez, P ;
Lindahl, G ;
Dahlbäck, B ;
Jonsson, AB .
JOURNAL OF IMMUNOLOGY, 2001, 166 (11) :6764-6770
[8]   Structural requirements for the complement regulatory activities of C4BP [J].
Blom, AM ;
Kask, L ;
Dahlbäck, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (29) :27136-27144
[9]  
BLOM AM, 2002, IN PRESS MOL IMMUNOL
[10]   HIGH MOLECULAR-WEIGHT COMPLEX IN HUMAN-PLASMA BETWEEN VITAMIN-K-DEPENDENT PROTEIN-S AND COMPLEMENT COMPONENT C4B-BINDING PROTEIN [J].
DAHLBACK, B ;
STENFLO, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (04) :2512-2516